SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Teresa Caballero Molina, María Pedrosa Delgado, Carmen Gómez Traseira, Angioedema hereditario, Medicina Clínica, 2015,

    CrossRef

  2. 2
    Mauro Cancian, Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency, Current Opinion in Allergy and Clinical Immunology, 2015, 15, 4, 383

    CrossRef

  3. 3
    Nicolas Javaud, Anne Gompel, Laurence Bouillet, Isabelle Boccon-Gibod, Delphine Cantin, Nadia Smaiti, Françoise Carpentier, Marouane Boubaya, David Launay, Frédéric Adnet, Olivier Fain, Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective study, Annals of Allergy, Asthma & Immunology, 2015, 114, 6, 499

    CrossRef

  4. 4
    Bernard Floccard, Nicolas Javaud, Jullien Crozon, Thomas Rimmelé, Prise en charge en urgence des angiœdèmes bradykiniques, La Presse Médicale, 2015, 44, 1, 70

    CrossRef

  5. 5
    Bernard Floccard, Nicolas Javaud, Jullien Crozon, Thomas Rimmelé, Prise en charge en urgence des angiœdèmes bradykiniques, Journal Européen des Urgences et de Réanimation, 2015, 27, 1, 40

    CrossRef

  6. 6
    Paula Busse, Anette Bygum, Jonathan Edelman, William Lumry, Thomas Machnig, Inmaculada Martinez-Saguer, Mikhail Rojavin, Safety of C1-Esterase Inhibitor in Acute and Prophylactic Therapy of Hereditary Angioedema: Findings from the Ongoing International Berinert Patient Registry, The Journal of Allergy and Clinical Immunology: In Practice, 2015, 3, 2, 213

    CrossRef

  7. 7
    Giuliana Ferrante, Valeria Scavone, Maria Muscia, Emilia Adrignola, Giovanni Corsello, Giovanni Passalacqua, Stefania La Grutta, The care pathway for children with urticaria, angioedema, mastocytosis, World Allergy Organization Journal, 2015, 8, 1, 5

    CrossRef

  8. 8
    W. Aberer, Angioedema is not just ‘deep urticaria’ but an entity of its own, Allergy, 2014, 69, 5
  9. 9
    Annette Feussner, Uwe Kalina, Peter Hofmann, Thomas Machnig, Georg Henkel, Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema, Transfusion, 2014, 54, 10
  10. 10
    Eveline Y. Wu, Michael M. Frank, Management of Hereditary Angioedema in Childhood, Pediatric Allergy, Immunology, and Pulmonology, 2014, 27, 4, 165

    CrossRef

  11. 11
    Konrad Bork, Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema, Immunotherapy, 2014, 6, 5, 533

    CrossRef

  12. 12
    Andrew J. MacGinnitie, Pediatric hereditary angioedema, Pediatric Allergy and Immunology, 2014, 25, 5
  13. 13
    Inmaculada Martinez-Saguer, Marco Cicardi, Chiara Suffritti, Eva Rusicke, Emel Aygören-Pürsün, Hildegard Stoll, Tanja Rossmanith, Annette Feussner, Uwe Kalina, Wolfhart Kreuz, Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study, Transfusion, 2014, 54, 6
  14. 14
    Jonathan A. Bernstein, Thomas Machnig, Heinz-Otto Keinecke, Glenn J. Whelan, Timothy J. Craig, The Effect of Weight on the Efficacy and Safety of C1 Esterase Inhibitor Concentrate for the Treatment of Acute Hereditary Angioedema, Clinical Therapeutics, 2014, 36, 4, 518

    CrossRef

  15. 15
    J. Shi, E. L. Rose, A. Singh, S. Hussain, N. E. Stagliano, G. C. Parry, S. Panicker, TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins, Blood, 2014, 123, 26, 4015

    CrossRef

  16. 16
    Ralph S. Shapiro, Lisa Zacek, Training Hereditary Angioedema Patients to Self-administer Intravenous C1 Esterase Inhibitor Concentrate, Journal of Infusion Nursing, 2014, 37, 4, 284

    CrossRef

  17. 17
    Neeti Bhardwaj, Timothy J. Craig, Treatment of hereditary angioedema: a review (CME), Transfusion, 2014, 54, 11
  18. 18
    K.J. Velthove, P.F.W. Strengers, A worldwide yearly survey of new data in adverse drug reactions and interactions, 2014,

    CrossRef

  19. 19
    J.D. Kreuter, J.B. Hagan, A worldwide yearly survey of new data in adverse drug reactions, 2014,

    CrossRef

  20. 20
    H. Henry Li, Marilyn Campion, Timothy J. Craig, Daniel F. Soteres, Marc Riedl, William R. Lumry, Andrew J. MacGinnitie, Elizabeth P. Shea, Jonathan A. Bernstein, Analysis of hereditary angioedema attacks requiring a second dose of ecallantide, Annals of Allergy, Asthma & Immunology, 2013, 110, 3, 168

    CrossRef

  21. 21
    T. Caballero, Angio-oedema due to hereditary C1 inhibitor deficiency in children, Allergologia et Immunopathologia, 2013, 41, 1, 45

    CrossRef

  22. 22
    N. Javaud, O. Fain, L. Martin, Angioedèmes bradykiniques, Réanimation, 2013, 22, 5, 449

    CrossRef

  23. 23
    Flint R Packer, C1 inhibitor concentrate treatment of multiple laryngeal attacks in a 53-year-old woman with hereditary angioedema, Immunotherapy, 2013, 5, 8, 855

    CrossRef

  24. 24
    Lynda Schneider, David Hurewitz, Richard Wasserman, Krystyna Obtulowicz, Thomas Machnig, Dumitru Moldovan, Avner Reshef, Timothy J. Craig, C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies, Pediatric Allergy and Immunology, 2013, 24, 1
  25. 25
    Timothy J. Craig, Mikhail A. Rojavin, Thomas Machnig, Heinz-Otto Keinecke, Jonathan A. Bernstein, Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks, Annals of Allergy, Asthma & Immunology, 2013, 111, 3, 211

    CrossRef

  26. 26
    Marc A. Riedl, Robyn J. Levy, Daniel Suez, Richard F. Lockey, James W. Baker, Anurag Relan, Bruce L. Zuraw, Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study, Annals of Allergy, Asthma & Immunology, 2013, 110, 4, 295

    CrossRef

  27. 27
    P. J. Busse, M. S. Buckland, Non-histaminergic angioedema: focus on bradykinin-mediated angioedema, Clinical & Experimental Allergy, 2013, 43, 4
  28. 28
    Jonathan A. Bernstein, On-demand Therapy for Hereditary Angioedema, Immunology and Allergy Clinics of North America, 2013, 33, 4, 487

    CrossRef

  29. 29
    Albert L. Sheffer, Andrew J. MacGinnitie, Marilyn Campion, Leslie E. Stolz, William E. Pullman, Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks, Annals of Allergy, Asthma & Immunology, 2013, 110, 3, 184

    CrossRef

  30. 30
    David W. Barbara, Kevin P. Ronan, Daniel E. Maddox, Mark A. Warner, Perioperative angioedema: background, diagnosis, and management, Journal of Clinical Anesthesia, 2013, 25, 4, 335

    CrossRef

  31. 31
    E. Aygören-Pürsün, I. Martinez Saguer, W. Kreuz, T. Klingebiel, D. Schwabe, Risk of angioedema following invasive or surgical procedures in HAE type I and II – the natural history, Allergy, 2013, 68, 8
  32. 32
    Aleena Banerji, The burden of illness in patients with hereditary angioedema, Annals of Allergy, Asthma & Immunology, 2013, 111, 5, 329

    CrossRef

  33. 33
    Andrea Zanichelli, Marta Mansi, Giulia Periti, Marco Cicardi, Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency, Expert Review of Clinical Immunology, 2013, 9, 5, 477

    CrossRef

  34. 34
    Y.-Y. Xu, L. V. Buyantseva, N. S. Agarwal, K. Olivieri, Y.-X. Zhi, T. J. Craig, Update on treatment of hereditary angioedema, Clinical & Experimental Allergy, 2013, 43, 4
  35. 35
    Mar Guilarte, Actualización en angioedema hereditario por déficit del inhibidor de C1, Medicina Clínica, 2012, 139, 10, 452

    CrossRef

  36. 36
    J. A. Bernstein, E. P. Shea, J. Koester, R. Iarrobino, W. E. Pullman, Assessment of rebound and relapse following ecallantide treatment for acute attacks of hereditary angioedema, Allergy, 2012, 67, 9
  37. 37
    K. Weller, A. Groffik, M. Magerl, N. Tohme, P. Martus, K. Krause, M. Metz, P. Staubach, M. Maurer, Development and construct validation of the angioedema quality of life questionnaire, Allergy, 2012, 67, 10
  38. 38
    R. Seidel, Erfolgreiche Anwendung von C1-Esterase-Inhibitor bei „capillary leak syndrome“, Der Anaesthesist, 2012, 61, 11, 954

    CrossRef

  39. 39
    V. Wahn, W. Aberer, W. Eberl, M. Faßhauer, T. Kühne, K. Kurnik, M. Magerl, D. Meyer-Olson, I. Martinez-Saguer, P. Späth, P. Staubach-Renz, W. Kreuz, Hereditäres Angioödem (HAE) im Kindes- und Jugendalter, Monatsschrift Kinderheilkunde, 2012, 160, 8, 774

    CrossRef

  40. 40
    V. Wahn, W. Aberer, W. Eberl, M. Faßhauer, T. Kühne, K. Kurnik, M. Magerl, D. Meyer-Olson, I. Martinez-Saguer, P. Späth, P. Staubach-Renz, W. Kreuz, Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies, European Journal of Pediatrics, 2012, 171, 9, 1339

    CrossRef

  41. 41
    C. Erik Hack, Maurice Mannesse, Aartie Baboeram, Beatrijs Oortwijn, Anurag Relan, Immunogenicity Assessment of Recombinant Human C1-Inhibitor, BioDrugs, 2012, 26, 5, 303

    CrossRef

  42. 42
    C. Erik Hack, Maurice Mannesse, Aartie Baboeram, Beatrijs Oortwijn, Anurag Relan, Immunogenicity Assessment of Recombinant Human C1-Inhibitor, BioDrugs, 2012, 26, 5, 303

    CrossRef

  43. 43
    Marc A. Riedl, David S. Hurewitz, Robyn Levy, Paula J. Busse, David Fitts, Ira Kalfus, Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial, Annals of Allergy, Asthma & Immunology, 2012, 108, 1, 49

    CrossRef

  44. 44
    Michael J. Prematta, Againdra K. Bewtra, Robyn J. Levy, Richard L. Wasserman, Kraig W. Jacobson, Thomas Machnig, Timothy J. Craig, Per-Attack Reporting of Prodromal Symptoms Concurrent with C1-Inhibitor Treatment of Hereditary Angioedema Attacks, Advances in Therapy, 2012, 29, 10, 913

    CrossRef

  45. 45
    Jonathan A. Bernstein, Joseph J. Moellman, Progress in the Emergency Management of Hereditary Angioedema: Focus on New Treatment Options in the United States, Postgraduate Medicine, 2012, 124, 3, 91

    CrossRef

  46. 46
    H. Farkas, Z. Zotter, D. Csuka, E. Szabó, Z. Nébenfűhrer, G. Temesszentandrási, L. Jakab, L. Varga, G. Harmat, I. Karádi, Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor – a long-term survey, Allergy, 2012, 67, 12